A Controlled Study of the Efficacy of Botulinum Toxin A (Botox) for the Treatment of Major Depressive Disorder (MDD)
Latest Information Update: 17 Jun 2015
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 01 May 2014 Status changed from active, no longer recruiting to completed according to results published in the Journal of Psychiatric Research.
- 21 Mar 2012 New trial record